It may never emerge back to the OTC. BP/funding news can also come out any day now too.. Assets could be distributed into different entities with shareholders getting a proportional slice. All we can do is speculate rough timelines for material events.
They mentioned strategic dealmaking at various stages of maturity a long time ago now. Everybody can read about the NIH tier 3 implementation phase/IND enabling phase and implications necessary to move forward into phase 1 clinicals. They need funds to move any and all assets forward.
Market Data 
Markets 
AI
